Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 2968-2976
Published online May 21, 2008. doi: 10.3748/wjg.14.2968
Published online May 21, 2008. doi: 10.3748/wjg.14.2968
Name | Mechanism | Effect in animal models | Result in human trials |
Somatostatin | Inhibition of pancreatic secretion | No reduced mortality | No reduced mortality |
Octreotid | Inhibition of pancreatic secretion | No effect (divergent results) | No reduced mortality |
Gabexate mesilate | Protease inhibitor | Reduced histology score | Maybe reduced mortality |
N-acetyl-cysteine | Reduction of oxidative stress | Reduced severity | No reduced mortality |
Nitrogen oxide | Improvement of micro-circulation | Reduced edema | No published trials |
Steroids | Non-specific anti-inflammatory | Reduced mortality | No published trials |
Interleukin-10 | Anti-inflammatory | Reduced mortality | No published trials |
TNF-alpha antibody | Specific anti-inflammatory | Reduced mortality | No published trials |
PAF inhibitor | Specific anti-inflammatory | No reduced mortality | No reduced mortality |
Antibiotics | Antibacterial | - | Reduced mortality |
Probiotics | Prevention of colonization of the gut | - | No reduced mortality |
- Citation: Bang UC, Semb S, Nøjgaard C, Bendtsen F. Pharmacological approach to acute pancreatitis. World J Gastroenterol 2008; 14(19): 2968-2976
- URL: https://www.wjgnet.com/1007-9327/full/v14/i19/2968.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2968